法洛四联症
先证者
生物
外显子组测序
心脏病
遗传学
生物信息学
病理
内科学
医学
突变
基因
作者
Paul Kruszka,Pranoot Tanpaiboon,Katherine Neas,Kathleen Crosby,Seth I. Berger,Ariel F. Martinez,Yonit A. Addissie,Yupada Pongprot,Rekwan Sittiwangkul,Suchaya Silvilairat,Krit Makonkawkeyoon,Lan Yu,Julia Wynn,James T. Bennett,Heather C. Mefford,William Reynolds,Xiaoqin Liu,Mathilda T.M. Mommersteeg,Wendy K. Chung,Cecilia Lo,Maximilian Muenke
标识
DOI:10.1136/jmedgenet-2017-104611
摘要
Background
Congenital heart disease (CHD) is a common birth defect affecting approximately 1% of newborns. Great progress has been made in elucidating the genetic aetiology of CHD with advances in genomic technology, which we leveraged in recovering a new pathway affecting heart development in humans previously known to affect heart development in an animal model. Methods
Four hundred and sixteen individuals from Thailand and the USA diagnosed with CHD and/or congenital diaphragmatic hernia were evaluated with chromosomal microarray and whole exome sequencing. The DECIPHER Consortium and medical literature were searched for additional patients. Murine hearts from ENU-induced mouse mutants and transgenic mice were evaluated using both episcopic confocal histopathology and troponin I stained sections. Results
Loss of function ROBO1 variants were identified in three families; each proband had a ventricular septal defect, and one proband had tetralogy of Fallot. Additionally, a microdeletion in an individual with CHD was found in the medical literature. Mouse models showed perturbation of the Slit-Robo signalling pathway, causing septation and outflow tract defects and craniofacial anomalies. Two probands had variable facial features consistent with the mouse model. Conclusion
Our findings identify Slit-Robo as a significant pathway in human heart development and CHD.
科研通智能强力驱动
Strongly Powered by AbleSci AI